Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Angiogenesis - PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2
Cancer Vaccines - Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
Menopause - Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
Aneurysm - Scientists at University of Cambridge target aneurysm
Cancer Vaccines - New cancer vaccines study findings reported from Cleveland Clinic
Congestive Heart Failure - Reports summarize congestive heart failure research from S. Goldman and co-authors
Drug Resistance - Researchers at University of Barcelona publish new data on drug resistance
Enzyme Research - Studies from P.C. Fong and co-researchers yield new data on enzyme research
Gynecology - Research from Columbia University has provided new data on gynecology
Heart Disease - Reports summarize heart disease research from Harvard University
Leishmaniasis - Data from A. Bensalah et al provide new insights into leishmaniasis
Pancreatic Cancer - Data from C.D. Blanke et al provide new insights into pancreatic cancer
Solid Cancer - Data on solid cancer detailed by A.R. Hanauske and co-authors
Antigenics Inc. - Antigenics Reports Second Quarter 2009 Financial Results
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Preliminary Data from Two Ongoing Clinical Trials of Its Investigational mTOR Inhibitor, Ridaforolimus, in Combination with Targeted Drugs
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Preliminary Results from Ongoing Clinical Trial of Its Investigational, Bcr-Abl Inhibitor – AP24534 – in Drug-Resistant Chronic Myeloid Leukemia
Atrophy - QuatRx Announces Further Positive Phase 3 Results for Ophena(TM) (Ospemifene Tablets) in Postmenopausal Vaginal Atrophy
Clinical Trial Research - PacificGMP and USC to Collaborate on Recombinant Protein Development and Manufacturing for Phase 1 Clinical Trial
Drug Development - QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System
Endometriosis - Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis
Hepatitis C Virus - Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
Incyte Corporation - Incyte Reports Second Quarter 2009 Financial Results and Provides Update on Drug Development Programs
Influenza - BioCryst Reports Second Quarter 2009 Financial Results and Provides Corporate Update
Interferon - Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
Osiris Therapeutics, Inc. - Osiris Achieves Milestone Payment for Progress Developing Stem Cell Therapy for Type 1 Diabetes
Pfizer Inc - Pfizer and Medivation Initiate Phase 3 Trial of Dimebon In Patients With Huntington Disease
Santarus, Inc. - Santarus to Present at BMO Capital Markets Focus on Healthcare Conference
Senesco Technologies, Inc. - Senesco Technologies Enters Into Agreements for Additional $700,000 In Financing
Tranzyme Pharma - Tranzyme Pharma Receives FDA Fast Track Status for Its Oral GI Prokinetic Drug Candidate TZP-102
Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia
